| This article has been cited by |
| 1 | Mirtazapine for the treatment of psychosis in Parkinson’s disease: Any silver linings? | |
| Abhishek Lenka |
| Annals of Movement Disorders.2020;3(1)69 |
| [DOI] |
|
| 2 | Pharmacological management of Parkinson’s disease in older people | |
| Nadia Mouchaileh,Andrew J. Hughes |
| Journal of Pharmacy Practice and Research.2020;50(5)445 |
| [DOI] |
|
| 3 | Pimavanserin and Parkinson’s Disease Psychosis: A Narrative Review | |
| Jamir Pitton Rissardo,Ícaro Durante,Idan Sharon,Ana Letícia Fornari Caprara |
| Brain Sciences.2022;12(10)1286 |
| [DOI] |
|
| 4 | A Pragmatic Approach to the Perioperative Management of Parkinson’s Disease | |
| Abhishek Lenka,Shivam Om Mittal,Guillaume Lamotte,Fernando Luis Pagan |
| Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.2021;48(3)299 |
| [DOI] |
|
| 5 | Management of psychiatric disorders in patients with parkinson's diseases | |
| Adarsh Tripathi,PawanKumar Gupta,Teena Bansal |
| Indian Journal of Psychiatry.2022;64(8)330 |
| [DOI] |
|
| 6 | Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease | |
| Abhishek Lenka,Gianluca Di Maria,Guillaume Lamotte,Laxman Bahroo,Joseph Jankovic |
| Expert Review of Neurotherapeutics.2022;22(6)489 |
| [DOI] |
|
| 7 | The role of mirtazapine in the management of psychosis in Parkinson’s disease | |
| NA Uvais |
| Annals of Movement Disorders.2020;3(1)67 |
| [DOI] |
|
